Crossmark

Letter to the Editor: Comment on: Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy

Crossref DOI link: https://doi.org/10.1007/s12029-021-00656-4

Published Online: 2021-06-26

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jonas, Eduard https://orcid.org/0000-0003-0123-256X
Krige, Jake https://orcid.org/0000-0002-7057-9156
Bernon, Marc https://orcid.org/0000-0002-7967-8548
License Information

Text and Data Mining valid from 2021-06-26

Version of Record valid from 2021-06-26
More Information

Article History

Accepted: 17 June 2021

First Online: 26 June 2021

Declarations

:

: The authors declare no competing interests.